Correlation Between Genmab AS and Legend Biotech
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Legend Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Legend Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Legend Biotech Corp, you can compare the effects of market volatilities on Genmab AS and Legend Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Legend Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Legend Biotech.
Diversification Opportunities for Genmab AS and Legend Biotech
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Genmab and Legend is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Legend Biotech Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Legend Biotech Corp and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Legend Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Legend Biotech Corp has no effect on the direction of Genmab AS i.e., Genmab AS and Legend Biotech go up and down completely randomly.
Pair Corralation between Genmab AS and Legend Biotech
Given the investment horizon of 90 days Genmab AS is expected to under-perform the Legend Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Genmab AS is 1.21 times less risky than Legend Biotech. The stock trades about -0.07 of its potential returns per unit of risk. The Legend Biotech Corp is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 3,254 in Legend Biotech Corp on November 1, 2024 and sell it today you would earn a total of 509.00 from holding Legend Biotech Corp or generate 15.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Genmab AS vs. Legend Biotech Corp
Performance |
| Timeline |
| Genmab AS |
| Legend Biotech Corp |
Genmab AS and Legend Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genmab AS and Legend Biotech
The main advantage of trading using opposite Genmab AS and Legend Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Legend Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend Biotech will offset losses from the drop in Legend Biotech's long position.| Genmab AS vs. Ascendis Pharma AS | Genmab AS vs. Apellis Pharmaceuticals | Genmab AS vs. Akero Therapeutics | Genmab AS vs. Blueprint Medicines Corp |
| Legend Biotech vs. Vaxcyte | Legend Biotech vs. Apellis Pharmaceuticals | Legend Biotech vs. Travere Therapeutics | Legend Biotech vs. Akero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |